Strs Ohio Sorrento Therapeutics, Inc. Transaction History

Strs Ohio

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 24, 2022	SELL	$4.65 - $7.23 $62,775 - $97,605	-13,500 Reduced 40.18%	20,100 $93,000
Q3 2021 Oct 22, 2021	BUY	$7.41 - $10.99 $214,149 - $317,611	28,900 Added 614.89%	33,600 $256,000
Q2 2021 Jul 26, 2021	BUY	$6.35 - $10.0 $29,845 - $47,000	4,700 New	4,700 $45,000
Q4 2018 Jan 23, 2019	SELL	$2.01 - $4.24 $93,464 - $197,160	-46,500 Closed	0 $0
Q2 2018 Aug 06, 2018	BUY	$4.75 - $8.0 $220,875 - $372,000	46,500 New	46,500 $334,000

5.51M

Ticker SRNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 449,952,000
Market Cap $148M
Description
Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

Stay updated on Strs Ohio with notifications on news.